Specialties
Regenerative Medicine
52 results found in 2ms
ChondroFiller injection for knee cartilage defectsChondroFiller injection for knee cartilage defects
The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.
ChondroFiller for focal knee defects versus early osteoarthritisChondroFiller for focal knee defects versus early osteoarthritis
Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.
ChondroFiller and Arthrosamid serve different knee conditionsChondroFiller and Arthrosamid serve different knee conditions
ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.
ChondroFiller for focal knee defects, not osteoarthritisChondroFiller for focal knee defects, not osteoarthritis
ChondroFiller is an injectable collagen scaffold that recruits a patient's own progenitor cells for cartilage repair. It works only on focal defects; chronic inflammation and cell depletion in osteoarthritis eliminate the biological conditions it requires.ChondroFiller is an injectable collagen scaffold that recruits a patient's own progenitor cells for cartilage repair. It works only on focal defects; chronic inflammation and cell depletion in osteoarthritis eliminate the biological conditions it requires.
ChondroFiller or Arthrosamid for your kneeChondroFiller or Arthrosamid for your knee
ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.
What the ChondroFiller evidence actually showsWhat the ChondroFiller evidence actually shows
ChondroFiller, a collagen scaffold, increaseskneefunction scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
How strong is ChondroFiller's clinical evidenceHow strong is ChondroFiller's clinical evidence
ChondroFiller produces clinically meaningful functional improvement of approximately 30 IKDC points inkneepatients, sustained at three-year follow-up, but published evidence extends no further, leaving long-term durability unproven.ChondroFiller produces clinically meaningful functional improvement of approximately 30 IKDC points in knee patients, sustained at three-year follow-up, but published evidence extends no further, leaving long-term durability unproven.
52 results found in 2ms